Brought to you by 
Series B brings in $7mm for Brickell Biotech
20 Mar 2013
Executive Summary
Brickell Biotech Inc. (dermatology therapeutics) has raised $7mm through its Series B venture round. AmorePacific Ventures, the VC arm of Korean aesthetics and cosmetics company AmorePacific Corp., led and was joined by current shareholder Palisade Concentrated Equity Partnership (managed by Palisade Capital Management).
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Series B brings in $7mm for Brickell Biotech
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice